ISIS 3521/CGP64128A antisense blocker of tyrosine kinase C-alpha: Phase II Update

Isis Pharmaceuticals Inc. (ISIP), Carlsbad, Calif.
Product:

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE